Focus: Hologic is a $4.0B public medical device company headquartered in Marlborough, MA, specializing in diagnostic imaging, surgical instruments, and women's health solutions. The company operates across breast cancer screening, cervical cancer diagnostics, gynecological procedures, and emerging oncology therapies.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Hologic to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Hologic's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Help build intelligence for Hologic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Ferring Pharmaceuticals to Acquire Fertility Startup Gameto for $1.38B - Femtech Insider
Ferring Pharmaceuticals to Acquire Fertility Startup Gameto for $1.38B Femtech Insider
Hologic and Inpeco Announce Co-Marketing Partnership to Advance Molecular Laboratory Automation - Press Release Hub
Hologic and Inpeco Announce Co-Marketing Partnership to Advance Molecular Laboratory Automation Press Release Hub
Hologic Signs Definitive Agreement to Acquire Reveal Genomics - STT Info
Hologic Signs Definitive Agreement to Acquire Reveal Genomics STT Info
MRI Based Quantitative Biomarkers Market Forecast to 2035: Growth Accelerates on Precision Medicine Demand - IndexBox
MRI Based Quantitative Biomarkers Market Forecast to 2035: Growth Accelerates on Precision Medicine Demand IndexBox
Sandoz leads pharma's best workplaces as Rare Cancers Australia makes healthcare list - PharmaDispatch
Sandoz leads pharma's best workplaces as Rare Cancers Australia makes healthcare list PharmaDispatch
5th Sustainability in Life Sciences Summit - pharmaphorum
5th Sustainability in Life Sciences Summit pharmaphorum
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae: Aligning Diagnostics, Regulation, Guidelines, and Reimbursement.
Clinical utility of nucleic acid amplification testing for detection of sexually transmitted infections in women with symptomatic bacterial vaginosis and vulvovaginal candidiasis identified by conventional versus molecular diagnoses.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo